Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
24.16 +0.64 (+2.72%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 24.16 unch (unch) 04/11/25
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
23.35
Day High
24.22
Open 23.73
Previous Close 23.52 23.52
Volume 482,700 482,700
Avg Vol 704,715 704,715
Stochastic %K 21.78% 21.78%
Weighted Alpha -49.45 -49.45
5-Day Change -2.45 (-9.21%) -2.45 (-9.21%)
52-Week Range 22.74 - 53.96 22.74 - 53.96
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,151,224
  • Shares Outstanding, K 47,650
  • Annual Sales, $ 731,970 K
  • Annual Income, $ 159,520 K
  • EBIT $ 205 M
  • EBITDA $ 264 M
  • 60-Month Beta 0.79
  • Price/Sales 1.53
  • Price/Cash Flow 4.70
  • Price/Book 1.54

Options Overview Details

View History
  • Implied Volatility 80.73% ( +4.48%)
  • Historical Volatility 45.35%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 80.73% on 04/11/25
  • IV Low 19.94% on 09/10/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 20
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 756
  • Open Int (30-Day) 923

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.66
  • Number of Estimates 1
  • High Estimate 0.66
  • Low Estimate 0.66
  • Prior Year 0.93
  • Growth Rate Est. (year over year) -29.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.74 +6.24%
on 04/10/25
Period Open: 27.33
29.27 -17.45%
on 04/01/25
-3.17 (-11.60%)
since 03/11/25
3-Month
22.74 +6.24%
on 04/10/25
Period Open: 36.36
39.01 -38.07%
on 01/15/25
-12.20 (-33.55%)
since 01/10/25
52-Week
22.74 +6.24%
on 04/10/25
Period Open: 40.15
53.96 -55.22%
on 11/06/24
-15.99 (-39.83%)
since 04/11/24

Most Recent Stories

More News
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 3, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating...

AMPH : 24.16 (+2.72%)
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes

AMPH : 24.16 (+2.72%)
New Strong Sell Stocks for March 24th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Avanos Medical, Inc. AVNS is a medical technology company focusing on delivering medical device solutions. The Zacks Consensus...

AVNS : 12.47 (+0.32%)
AIRS : 1.8200 (+1.11%)
AMPH : 24.16 (+2.72%)
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

VTRS : 7.54 (+3.86%)
AMPH : 24.16 (+2.72%)
ANIP : 68.12 (+4.61%)
AMRX : 6.98 (+0.14%)
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

VTRS : 7.54 (+3.86%)
ANIP : 68.12 (+4.61%)
AMPH : 24.16 (+2.72%)
AMRX : 6.98 (+0.14%)
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...

AMPH : 24.16 (+2.72%)
Amphastar: Earnings Miss, Margins Drop

Amphastar Pharmaceuticals posted modest earnings growth but fell short of market expectations in its latest quarterly results.

AMPH : 24.16 (+2.72%)
Amphastar: Q4 Earnings Snapshot

Amphastar: Q4 Earnings Snapshot

AMPH : 24.16 (+2.72%)
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%

AMPH : 24.16 (+2.72%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

Reports Net Revenues of $186.5 Million for the Three Months Ended December 31, 2024

AMPH : 24.16 (+2.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

3rd Resistance Point 25.33
2nd Resistance Point 24.77
1st Resistance Point 24.47
Last Price 24.16
1st Support Level 23.60
2nd Support Level 23.04
3rd Support Level 22.74

See More

52-Week High 53.96
Fibonacci 61.8% 42.03
Fibonacci 50% 38.35
Fibonacci 38.2% 34.66
Last Price 24.16
52-Week Low 22.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar